Wuxi Biologics (Cayman), Inc.

65
Hold
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG970081173
HKD
32.72
-0.12 (-0.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Wuxi Biologics (Cayman), Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
7,870.00
5,241.00
4,612.00
6,230.00
4,812.00
2,205.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1,877.00
-867.00
-990.00
-1,133.00
-1,161.00
-412.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
7,112.00
5,813.00
5,158.00
6,459.00
4,117.00
2,109.00
Cash Flow from Investing Activities
-3,766.00
-5,852.00
-3,488.00
-6,336.00
-11,653.00
-7,844.00
Cash Flow from Financing Activities
-2,173.00
-1,559.00
2,087.00
-3,562.00
9,994.00
7,226.00
Net Cash Inflow / Outflow
1,003.00
-1,507.00
3,618.00
-3,032.00
2,298.00
1,109.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-168.00
91.00
-139.00
407.00
-158.00
-382.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Wuxi Biologics (Cayman), Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
7870.28524066062
5271.39308385907
2,599.00
49.30%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1877.40430825412
1234.2667660914
-3,111.00
-252.11%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
7112.53201510683
6566.08623859717
546.00
8.32%
Cash Flow from Investing Activities
-3766.95744730707
-4594.49975177798
828.00
18.01%
Cash Flow from Financing Activities
-2173.82081332317
-2719.54646633716
546.00
20.07%
Net Cash Inflow / Outflow
1003.42705115347
-753.180875024643
1,756.00
233.23%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-168.326703323117
-5.22089550667136
-163.00
-3124.10%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 22.35% vs 12.70% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
7,112.53
5,813.10
22.35%